SCHEMBL19965965

SCHEMBL19965965

S=P(c1ccccc1)(c1ccccc1)c1ccc2nc3c4ccccc4c4ccc(-c5ccc6c(ccc7ccccc76)c5)cc4n3c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
KDM4E B2RXH2 4/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 3/20 0.32
HSD17B10 Q99714 2/20 0.32
LMNA P02545 2/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
HIF1A Q16665 1/20 0.32
CYP1B1 Q16678 1/20 0.32
AHR P35869 1/20 0.32
SRC P12931 1/20 0.32
MEN1 O00255 1/20 0.30
HPRT1 P00492 1/20 0.30
NPC1 O15118 1/20 0.30
RECQL P46063 1/20 0.30
RAB9A P51151 1/20 0.30
METAP2 P50579 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960026 0.93 HPGD (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960020 0.92 HPGD (0.40) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960339 0.91 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960506 0.89 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960022 0.89 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960024 0.89 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19965958 0.89 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960268 0.88 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19959922 0.88 KDM4E (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960333 0.88 AHR (0.33) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.